Agilon Health Inc [AGL] stock prices are up 14.83% to $5.73 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AGL shares have gain 3.99% over the last week, with a monthly amount drifted -11.57%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 27, February 2024, agilon health Reports Fourth Quarter 2023 Results. In a post published today on Yahoo Finance, Revenue increased 72% to $1.06 billion in the fourth quarter 2023, Medicare Advantage membership increased 68% to 388,400, and total members on the agilon platform grew to 477,700 as of December 31, 2023.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on March 06, 2024, when Barclays initiated its Underweight rating and assigned the stock a price target of $5. Previously, TD Cowen downgraded its rating to Market Perform on February 26, 2024, and dropped its price target to $6.50. On February 26, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $6.50 on the stock. Wolfe Research downgraded its rating to a Peer Perform. Stifel downgraded its rating to a Hold. Leerink Partners downgraded its rating to Market Perform for this stock on January 08, 2024. In a note dated January 05, 2024, Truist downgraded an Hold rating on this stock and revised its target price from $23 to $10.
The stock price of Agilon Health Inc [AGL] has been fluctuating between $4.44 and $29.44 over the past year. Currently, Wall Street analysts expect the stock to reach $33 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $5.73 at the most recent close of the market. An investor can expect a potential return of 475.92% based on the average AGL price forecast.
Analyzing the AGL fundamentals
The Agilon Health Inc [NYSE:AGL] reported sales of 4.56B for trailing twelve months, representing a surge of 53.10%. Gross Profit Margin for this corporation currently stands at 0.01% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.25 and Total Capital is -0.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.27 points at the first support level, and at 4.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.97, and for the 2nd resistance point, it is at 6.22.
Agilon Health Inc [AGL] reported earnings per share of -$0.57 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.3/share, meaning a difference of -$0.27 and a surprise factor of -90.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.08 per share as compared to estimates of -$0.06 per share, a difference of -$0.02 representing a surprise of -33.30%.
Ratios To Look Out For
It’s worth pointing out that Agilon Health Inc [NYSE:AGL]’s Current Ratio is 1.51. Also, the Quick Ratio is 1.51, while the Cash Ratio stands at 0.12. Considering the valuation of this stock, the price to sales ratio is 0.51, the price to book ratio is 3.52.
Transactions by insiders
Recent insider trading involved Schwaneke Jeffrey A., Director, that happened on Nov 29 ’23 when 22300.0 shares were purchased. Chief Markets Officer, Shaker Benjamin completed a deal on Sep 13 ’23 to sell 18750.0 shares. Meanwhile, Chief Markets Officer Shaker Benjamin sold 18750.0 shares on Sep 12 ’23.
